LWCFA
ABMD
Loring Wolcott & Coolidge Fiduciary Advisors’s Abiomed Inc ABMD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-15,692
| Closed | -$3.86M | – | 614 |
|
|
2022
Q3 | $3.86M | Hold |
15,692
| – | – | 0.05% | 89 |
|
|
2022
Q2 | $3.88M | Sell |
15,692
-8
| -0.1% | -$1.98K | 0.05% | 92 |
|
|
2022
Q1 | $5.2M | Sell |
15,700
-790
| -5% | -$262K | 0.05% | 88 |
|
|
2021
Q4 | $5.92M | Hold |
16,490
| – | – | 0.05% | 87 |
|
|
2021
Q3 | $5.37M | Hold |
16,490
| – | – | 0.05% | 86 |
|
|
2021
Q2 | $5.15M | Hold |
16,490
| – | – | 0.05% | 87 |
|
|
2021
Q1 | $5.26M | Sell |
16,490
-85
| -0.5% | -$27.1K | 0.06% | 82 |
|
|
2020
Q4 | $5.37M | Hold |
16,575
| – | – | 0.06% | 80 |
|
|
2020
Q3 | $4.59M | Sell |
16,575
-385
| -2% | -$107K | 0.06% | 84 |
|
|
2020
Q2 | $4.1M | Buy |
16,960
+490
| +3% | +$118K | 0.06% | 85 |
|
|
2020
Q1 | $2.39M | Buy |
16,470
+545
| +3% | +$79.1K | 0.04% | 95 |
|
|
2019
Q4 | $2.72M | Buy |
15,925
+1,620
| +11% | +$276K | 0.04% | 103 |
|
|
2019
Q3 | $2.54M | Buy |
14,305
+4,695
| +49% | +$835K | 0.04% | 106 |
|
|
2019
Q2 | $2.5M | Buy |
9,610
+9,602
| +120,025% | +$2.5M | 0.04% | 108 |
|
|
2019
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 660 |
|
|
2018
Q4 | $3K | Hold |
8
| – | – | ﹤0.01% | 621 |
|
|
2018
Q3 | $4K | Hold |
8
| – | – | ﹤0.01% | 576 |
|
|
2018
Q2 | $3K | Hold |
8
| – | – | ﹤0.01% | 601 |
|
|
2018
Q1 | $2K | Hold |
8
| – | – | ﹤0.01% | 679 |
|
|
2017
Q4 | $1K | Hold |
8
| – | – | ﹤0.01% | 726 |
|
|
2017
Q3 | $1K | Buy |
+8
| New | +$1K | ﹤0.01% | 759 |
|